Dr. Khadija Benlhassan
Chief Scientific Officer

Biotechnology executive and entrepreneur with over 20 years’ experience in preclinical and clinical research programs; Currently Expert for European Community, founding director of Voynich Biosciences Inc, Chief scientific officer of Wellness Group Intl SA, Chair SAB of Applied Discovery Inc. and Chief Scientific Officer of Laureola Advisors Inc.. Past experience includes being a director, board member and Chief Scientific Officer at ImmunoClin Corporation (IMCL) and consultant for pharmaceutical industry.

Dr Benlhassan holds a PhD in Immunology from the Paris Descartes (Paris V) University and worked in the past at French Atomic Energy Commission (CEA) in France, Biopharm Centre of Excellence in Drug Discovery at GlaxoSmithKline R&D, UK and at Health Benefits & Immunology department at DANONE Research Centre, France.